[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,135,838
  • Shares Outstanding, K 32,434
  • Annual Sales, $ 780,570 K
  • Annual Income, $ 62,870 K
  • EBIT $ 189 M
  • EBITDA $ 414 M
  • 60-Month Beta 0.73
  • Price/Sales 1.45
  • Price/Cash Flow 2.29
  • Price/Book 3.61

Options Overview Details

View History
  • Implied Volatility 63.36% (+1.73%)
  • Historical Volatility 36.28%
  • IV Percentile 76%
  • IV Rank 54.82%
  • IV High 88.16% on 03/11/26
  • IV Low 33.26% on 08/18/25
  • Expected Move (DTE 2) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 1.83
  • Today's Open Interest 1,035
  • Open Int (30-Day) 977
  • Expected Range 35.96 to 35.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.48
  • Number of Estimates 2
  • High Estimate $1.53
  • Low Estimate $1.42
  • Prior Year $1.47
  • Growth Rate Est. (year over year) +0.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.69 +13.03%
on 06/17/26
38.49 -6.95%
on 07/07/26
+1.63 (+4.77%)
since 06/15/26
3-Month
30.13 +18.88%
on 06/03/26
40.50 -11.56%
on 05/08/26
+0.89 (+2.55%)
since 04/15/26
52-Week
29.19 +22.71%
on 08/01/25
50.79 -29.47%
on 12/29/25
+3.82 (+11.94%)
since 07/15/25

Most Recent Stories

More News
1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm

COLL : 35.83 (+2.31%)
FOUR : 52.62 (+5.22%)
FLNC : 15.07 (-3.46%)
1 Mooning Stock to Own for Decades and 2 That Underwhelm

1 Mooning Stock to Own for Decades and 2 That Underwhelm

COLL : 35.83 (+2.31%)
TREX : 43.79 (-0.86%)
ALHC : 21.12 (-0.38%)
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

2 Profitable Stocks to Keep an Eye On and 1 We Brush Off

ULTA : 467.51 (-0.34%)
COLL : 35.83 (+2.31%)
HAPN : 20.09 (+0.70%)
3 of Wall Street’s Favorite Stocks We Approach with Caution

3 of Wall Street’s Favorite Stocks We Approach with Caution

COLL : 35.83 (+2.31%)
SUPN : 47.23 (+1.22%)
REAX : 2.08 (+4.00%)
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan...

COLL : 35.83 (+2.31%)
2 Reasons to Sell COLL and 1 Stock to Buy Instead

2 Reasons to Sell COLL and 1 Stock to Buy Instead

COLL : 35.83 (+2.31%)
Collegium to Participate in 2026 Jefferies Global Healthcare Conference

STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global...

COLL : 35.83 (+2.31%)
3 Growth Stocks We’re Skeptical Of

3 Growth Stocks We’re Skeptical Of

GH : 162.53 (+1.51%)
COLL : 35.83 (+2.31%)
GATX : 177.53 (-0.12%)
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

COLL : 35.83 (+2.31%)
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 35.83 (+2.31%)
TMO : 535.82 (+0.33%)
XRAY : 13.17 (+3.70%)
HALO : 75.79 (+0.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 36.48
2nd Resistance Point 35.88
1st Resistance Point 35.45
Last Price 35.83
1st Support Level 34.42
2nd Support Level 33.82
3rd Support Level 33.39

See More

52-Week High 50.79
Fibonacci 61.8% 42.54
Fibonacci 50% 39.99
Fibonacci 38.2% 37.44
Last Price 35.83
52-Week Low 29.19

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.